Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Al Razi Pharma Industries is a prominent Syrian pharmaceutical manufacturing company based in Aleppo. Established in 1992, the company focuses on the development and production of a wide range of generic essential medicines across multiple therapeutic areas, including anti-infectives, cardiovascular, and gastrointestinal health. The company operates a large-scale manufacturing facility that complies with Good Manufacturing Practice (GMP) standards, serving both the domestic Syrian market and various export markets in the Middle East and North Africa. Al Razi Pharma is recognized as one of the leading industrial pharmaceutical entities in the region, maintaining a robust portfolio of oral solids, liquids, and semi-solid formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Al Razi Pharma Industries.